Methods for simultaneous amplification of target loci
First Claim
Patent Images
1. A method of amplifying target loci in a nucleic acid sample, the method comprising:
- (a) contacting a sample comprising target human loci with a library of at least 50 non-immobilized, non-identical primers that simultaneously hybridize to at least 50 non-identical target human loci to produce a reaction mixture;
wherein the primers do not include molecular inversion probes (MIPs);
(b) subjecting the reaction mixture to primer extension reaction conditions to produce amplified products comprising target amplicons;
wherein the annealing temperature for the reaction conditions is greater than a melting temperature of the at least 50 non-identical primers;
wherein the length of the annealing step of the reaction conditions is greater than 5 minutes; and
wherein at least 50 non-identical target human loci are simultaneously amplified; and
(c) sequencing the amplified products.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.
267 Citations
24 Claims
-
1. A method of amplifying target loci in a nucleic acid sample, the method comprising:
-
(a) contacting a sample comprising target human loci with a library of at least 50 non-immobilized, non-identical primers that simultaneously hybridize to at least 50 non-identical target human loci to produce a reaction mixture;
wherein the primers do not include molecular inversion probes (MIPs);(b) subjecting the reaction mixture to primer extension reaction conditions to produce amplified products comprising target amplicons;
wherein the annealing temperature for the reaction conditions is greater than a melting temperature of the at least 50 non-identical primers;
wherein the length of the annealing step of the reaction conditions is greater than 5 minutes; and
wherein at least 50 non-identical target human loci are simultaneously amplified; and(c) sequencing the amplified products. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
-
Specification